ropinirole
SpainDrugs containing this active substance
-
It is used to treat moderate to severe symptoms of Restless Legs Syndrome, a condition that causes an irresistible urge to move the legs and uncomfortable sensations such as tingling or burning.
Form: tablets, film-coated
Active substance Dosage ropinirole 0,25 mg Manufacturer: Glaxosmithkline S.A.
-
It is used to treat moderate to severe symptoms of Restless Legs Syndrome, helping to reduce the urge to move the legs and other limbs.
Form: tablets, film-coated
Active substance Dosage ropinirole 0,50 mg Manufacturer: Glaxosmithkline S.A.
-
It is used to treat moderate to severe symptoms of Restless Legs Syndrome, helping to reduce the urge to move the legs and other limbs.
Form: tablets, film-coated
Active substance Dosage ropinirole 2 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of Parkinson's disease, helping to reduce symptoms by acting similarly to dopamine in the brain.
Form: tablets, film-coated
Active substance Dosage ropinirole 0,25 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of Parkinson's disease, helping to reduce its symptoms by acting similarly to dopamine in the brain.
Form: tablets, film-coated
Active substance Dosage ropinirole 0,5 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of Parkinson's disease, helping to reduce its symptoms by acting similarly to dopamine in the brain.
Form: tablets, film-coated
Active substance Dosage ropinirole 1 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of Parkinson's disease, helping to reduce its symptoms by acting similarly to dopamine in the brain.
Form: tablets, film-coated
Active substance Dosage ropinirole 2 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of Parkinson's disease, helping to reduce symptoms by acting similarly to dopamine in the brain.
Form: tablets, film-coated
Active substance Dosage ropinirole 5 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of Parkinson's disease, helping to reduce symptoms by acting similarly to dopamine in the brain.
Form: tablets, prolonged-release
Active substance Dosage ropinirole 2 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of Parkinson's disease, helping to reduce symptoms by acting similarly to dopamine in the brain.
Form: tablets, prolonged-release
Active substance Dosage ropinirole 4 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the treatment of Parkinson's disease, helping to reduce symptoms by acting similarly to dopamine in the brain.
Form: tablets, prolonged-release
Active substance Dosage ropinirole 8 mg Manufacturer: Glaxosmithkline S.A.